# Investigation of Monkeypox and Other Zoonotic Diseases in the Democratic Republic of the Congo (DRC)

Source: https://welltoldgrants.com/grants/rfa-ck-22-001-investigation-of-monkeypox-and-other-zoonotic-diseases-in/  
Official notice: https://www.grants.gov/search-results-detail/337529

> Centers for Disease Control and Prevention - ERA offered grants of up to $700,000 (at least $600,000) to the applicants described in the notice. It expected to make one award worth $3.5 million in total. Applications closed on February 28, 2022.

| Field | Value |
|---|---|
| Opportunity number | RFA-CK-22-001 |
| Agency | Centers for Disease Control and Prevention - ERA |
| Status | Forecast |
| Deadline | February 28, 2022 |
| Award ceiling | $700,000 |
| Award floor | $600,000 |
| Expected awards | 1 |
| Total funding | $3.5 million |
| Cost sharing | not required |
| Assistance Listings | 93.084 |

## Who can apply

- Others (see text field entitled "Additional Information on Eligibility" for clarification)

The Kinshasa School of Public Health (KSPH) is the only eligible applicant.

## What the grant funds

The purpose of this notice of funding opportunity (NOFO) is to investigate the epidemiological, ecological, and anthropological aspects of monkeypox and assess clinical intervention strategies in the Democratic Republic of the Congo (DRC), including one study site in Tshuapa Province. This research may also extend to other zoonotic and vaccine-preventable diseases that are of importance in the DRC. Research activities should focus on improvement and evaluation of laboratory-based surveillance systems, investigations of viral reservoirs and the human-animal interface, epidemiologic investigations, genome sequencing and phylogenetic analysis, risk mitigation, enhancing health communication strategies, and clinical evaluation of vaccines and therapeutic treatments. The research supported by this NOFO should provide the DRC Ministry of Health and other key stakeholders with evidence-based strategies to develop important interventions and public health strategies.

## Questions people ask

### Is RFA-CK-22-001 still open?

No. It closed on February 28, 2022. A newer notice is open: PA-27-100, due dates in the notice, expires April 5, 2027.

### Who can apply for Investigation of Monkeypox and Other Zoonotic Diseases in the Democratic Republic of the Congo (DRC)?

Centers for Disease Control and Prevention - ERA accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Investigation of Monkeypox and Other Zoonotic Diseases in the Democratic Republic of the Congo (DRC)?

Closed February 28, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $700,000 each. About $3.5 million in total for one award.

### Who has won Prevention of Disease, Disability, and Death by Infectious Diseases   grants before?

The largest recipients over five fiscal years were Puerto Rico Science, Technology, and Research Trust, Massachusetts Department of Public Health, Emory University. The program made 128 awards worth $241 million in that time.